Phimosis: A rare complication of immunotherapy with durvalumab

We present a case of a 69 year old man with phimosis associated with immunotherapy with durvalumab for metastatic non-small-cell lung cancer. The patient developed vitiligo like dermatosis after the induction dose of durvalumab, subsequent administration of the immunotherapy the patient developed a...

Full description

Bibliographic Details
Main Authors: Luis Gabriel Vázquez-Lavista, Luis Llorente, Jorge Alatorre-Alexander, José Arturo Ramírez-Muciño
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Urology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442020302394